COVID-19 Vaccine, Neurodiverse Theater, South Dakota Trusts

Uncertainty Over Cost and Access to Future COVID-19 Exposes Flaws in US Drug System (0:30) Guest: Robin Feldman, Arthur J. Goldberg Distinguished Professor of Law, Director of the Center for Innovation at University of California Hastings, Author of "Drugs, Money, & Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices" A vaccine for COVID-19 is currently being tested on humans in Seattle, but it’ll be at least a year before it’s available publicly. Even then, it’s unclear who will be able to afford it. That all depends on how much the drug company that develops the vaccine decides to charge for it and how much of that cost health insurers will cover. You would think that a vaccine like this would be somehow made available to everyone regardless of cost – but that’s not how our system works, says Robin Feldman. Emotionally Intelligent Bosses (22:38) Guest: Zorana Ivcevic Pringle, Research Scientist for the Yale Center for Emotional Intelligence If you’re working from home now, tensions might be high between you, your boss, and other coworkers. Remote working sure makes it easy for miscommunications to happen. But a new study out of Yale University shows that if supervisors recognize and acknowledge high emotions, employees are happier and more creative. And not just when we’re all in crisis. Community Theater for Neurodiverse Performers and Audiences (39:26) Guest: Karalyn Joseph, Student at Harvard University, Founder and Director of the Community of Actors Sharing in Theatre (C.A.S.T.). As a high school junior, Karalyn Joseph started a community theater program for people with disabilities. Today, Joseph is a junior at Harvard, studying theater and neuroscience and she continues to direct the C.A.S.T. Theatre group in her Pennsylvania hometown. Apple Seed (50:40) Guest: Sam Payne, Host, The Apple Seed, BYUradio Sam Payne waxes nostalgic on one of the best tricks on April Fool's Day. Prosecutors Are Using Rap Lyrics as Evidence in Court (1:03:05) Guest: Erik Nielson, Associate Profes